Gilead Sciences
GILD
GILD
1,870 hedge funds and large institutions have $98.4B invested in Gilead Sciences in 2024 Q4 according to their latest regulatory filings, with 286 funds opening new positions, 644 increasing their positions, 719 reducing their positions, and 92 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
1.49% more ownership
Funds ownership: 83.74% → 85.23% (+1.5%)
10% less call options, than puts
Call options by funds: $864M | Put options by funds: $959M
10% less repeat investments, than reductions
Existing positions increased: 644 | Existing positions reduced: 719
Holders
1,870
Holding in Top 10
27
Calls
$864M
Puts
$959M
Top Buyers
| 1 | +$969M | |
| 2 | +$661M | |
| 3 | +$522M | |
| 4 |
Bank of New York Mellon
New York
|
+$261M |
| 5 |
Morgan Stanley
New York
|
+$261M |
Top Sellers
| 1 | -$447M | |
| 2 | -$410M | |
| 3 | -$356M | |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$264M |
| 5 |
Two Sigma Advisers
New York
|
-$205M |